China Pharma Holdings Inc (CPHI): Conf call point of note was that they in...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Wednesday, 11/22/2006 3:23:42 PM

Wednesday, November 22, 2006 3:23:42 PM

Conf call point of note was that they increased inventory in anticipation of a stronger q4 selling season.

Keep Last Read

Replies (1) Next 10 Prev Next

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:05:54 PM
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity • PR Newswire (US) • 05/14/2026 12:56:00 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/01/2026 08:15:23 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2026 08:05:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 09:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 09:49:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2026 09:05:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 09:05:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2025 09:49:53 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:10:24 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/04/2025 09:05:17 PM

Go Ad-Free